AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34181195 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-course methotrexate (MTX)
Number of subjects: 276
Study 34181195 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-course methotrexate + dactinomycin (ACTD)
Number of subjects: 276
Study 34181195 — intervention group
Group type: COMPARATOR
Intervention: Multi-course methotrexate (control arm)
Number of subjects: 276
Study 34212917 — intervention group
Group type: EXPERIMENTAL
Intervention: HPLT + Glucosamine sulfate 1500mg (GS - Dona®)
Number of subjects: 90
Study 34212917 — intervention group
Group type: COMPARATOR
Intervention: HPLT + placebo
Number of subjects: 90
Study 32718783 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led lifestyle intervention
Number of subjects: 292
Study 32718783 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 292
Study 35238704 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard del Nido cardioplegia solution (SDN)
Number of subjects: 80
Study 35238704 — intervention group
Group type: COMPARATOR
Intervention: Modified del Nido cardioplegia solution (MDN)
Number of subjects: 80
Study 33397862 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscope (VL)
Number of subjects: 146
Study 33397862 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscope (DL)
Number of subjects: 146
Study 32433753 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 2g temocillin
Number of subjects: 8
Study 32433753 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of 2g temocillin
Number of subjects: 8
Study 35716425 — intervention group
Group type: COMPARATOR
Intervention: Indeterminate stress ECG during exercise imaging stress test (EIST)
Number of subjects: 0
Study 35716425 — intervention group
Group type: COMPARATOR
Intervention: Discordant stress ECG during exercise imaging stress test (EIST)
Number of subjects: 0
Study 35716425 — intervention group
Group type: COMPARATOR
Intervention: Indeterminate stress ECG during vasodilator nuclear stress test (PIST)
Number of subjects: 0
Study 35716425 — intervention group
Group type: COMPARATOR
Intervention: Discordant stress ECG during vasodilator nuclear stress test (PIST)
Number of subjects: 0
Study 33241757 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparing of puboprostatic ligaments (PPLs) during laparoscopic radical prostatectomy
Number of subjects: 74
Study 33241757 — intervention group
Group type: COMPARATOR
Intervention: Division of puboprostatic ligaments (PPLs) during laparoscopic radical prostatectomy
Number of subjects: 74
Study 33847758 — intervention group
Group type: EXPERIMENTAL
Intervention: COBMINDEX
Number of subjects: 116
Study 33847758 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 116
Study 32090996 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laser scanner (3DLS) and tablet computer for digitally assisted BCRL assessment
Number of subjects: 0
Study 35357402 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly aspherical lenslets (HAL)
Number of subjects: 157
Study 35357402 — intervention group
Group type: EXPERIMENTAL
Intervention: Slightly aspherical lenslets (SAL)
Number of subjects: 157
Study 35357402 — intervention group
Group type: COMPARATOR
Intervention: Single-vision spectacle lenses (SVL)
Number of subjects: 157
Study 34566523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/day plus rosuvastatin 20 mg/day (combination group)
Number of subjects: 171
Study 34566523 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin 20 mg/day (rosuvastatin group)
Number of subjects: 171
Study 32433648 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate
Number of subjects: 304
Study 32433648 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active participants
Number of subjects: 304
Study 32433648 — intervention group
Group type: COMPARATOR
Intervention: Casting (Control)
Number of subjects: 304
Study 34818966 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane foam dressing
Number of subjects: 110
Study 34818966 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 110
Study 34478869 — intervention group
Group type: EXPERIMENTAL
Intervention: CHATO education (n = 64)
Number of subjects: 128
Study 34478869 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 64)
Number of subjects: 128
Study 35753872 — intervention group
Group type: COMPARATOR
Intervention: Detuned laser (placebo)
Number of subjects: 30
Study 35753872 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (active)
Number of subjects: 30
Study 34310400 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg V-01 (two-dose regimen)
Number of subjects: 880
Study 34310400 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 μg V-01 (two-dose regimen)
Number of subjects: 880
Study 34310400 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μg V-01 (one-dose regimen)
Number of subjects: 880
Study 34310400 — intervention group
Group type: EXPERIMENTAL
Intervention: V-01 (both regimens)
Number of subjects: 880
Study 34310400 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two-dose regimen)
Number of subjects: 880
Study 34310400 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one-dose regimen)
Number of subjects: 880
Study 32769506 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid intake group (allowed to drink up to 400 ml of apple juice for 90 minutes after randomisation)
Number of subjects: 125
Study 32769506 — intervention group
Group type: COMPARATOR
Intervention: Fasting group (nil by mouth)
Number of subjects: 125
Study 34044246 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP)
Number of subjects: 970
Study 34044246 — intervention group
Group type: COMPARATOR
Intervention: ICD-10
Number of subjects: 970
Study 32660769 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB11455 (6 mg/0.6 mL)
Number of subjects: 292
Study 32660769 — intervention group
Group type: COMPARATOR
Intervention: Reference Pegfilgrastim (Neulasta) (6 mg/0.6 mL)
Number of subjects: 292
Study 36395190 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal and external (visual, auditory, tactile) cues during walking tasks
Number of subjects: 80
Study 34310489 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities Completed over Time in 24 Hours (ACT24) previous day recalls
Number of subjects: 2640
Study 34310489 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure time sedentary behavior
Number of subjects: 2640
Study 33087083 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual financial incentives (IND)
Number of subjects: 847
Study 33087083 — intervention group
Group type: EXPERIMENTAL
Intervention: Group financial incentives (GRP)
Number of subjects: 847
Study 33087083 — intervention group
Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 847
Study 34498320 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted soccer programme (twice a week for 16 weeks)
Number of subjects: 25
Study 34498320 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual daily regime)
Number of subjects: 25
Study 33962594 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: One additional dose of 1g IV‐TXA 3 hours postoperatively
Number of subjects: 97
Study 33962594 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: Three doses of 1g IV‐TXA at 3, 6, and 12 hours postoperatively
Number of subjects: 97
Study 33962594 — intervention group
Group type: COMPARATOR
Intervention: Group A
Number of subjects: 97
Study 33962594 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 97
Study 35914916 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic surgery plus HIPEC CO2 with mitomycin
Number of subjects: 388
Study 35914916 — intervention group
Group type: COMPARATOR
Intervention: Standard surgery
Number of subjects: 388
Study 33742418 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer vision algorithm
Number of subjects: 7
Study 33742418 — intervention group
Group type: COMPARATOR
Intervention: Manual annotation by human annotators
Number of subjects: 7
Study 33742418 — intervention group
Group type: EXPERIMENTAL
Intervention: Both manual annotation and computer vision algorithm
Number of subjects: 7
Study 32347885 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 27564
Study 36067589 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 g/d of dry roasted, unsalted peanuts for 6 weeks
Number of subjects: 50
Study 36067589 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric lower-fat higher-carbohydrate (LFHC) snack for 6 weeks
Number of subjects: 50
Study 33825414 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at both Zusanli (ST36) and Zhongwan (CV12)
Number of subjects: 65
Study 33825414 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture at Zhongwan (CV12) alone
Number of subjects: 65
Study 36205248 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily for 45 days
Number of subjects: 10000
Study 33829580 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-PD-1/PD-L1 inhibitors (nivolumab, pembrolizumab, or atezolizumab)
Number of subjects: 249
Study 32878758 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative endoscopic injection of botulinum toxin (BTX) into the sphincter of Oddi
Number of subjects: 60
Study 32878758 — intervention group
Group type: COMPARATOR
Intervention: No preoperative endoscopy (Control)
Number of subjects: 60
Study 35894971 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Unidas for Health and Wellness (FUHW)
Number of subjects: 280
Study 35894971 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 280
Study 34820909 — intervention group
Group type: EXPERIMENTAL
Intervention: 550 mg/d supplemental choline (as choline chloride)
Number of subjects: 0
Study 34820909 — intervention group
Group type: COMPARATOR
Intervention: 25 mg/d d9-choline (control)
Number of subjects: 0
Study 34630560 — intervention group
Group type: EXPERIMENTAL
Intervention: Associated Mirror Therapy (AMT)
Number of subjects: 36
Study 34630560 — intervention group
Group type: COMPARATOR
Intervention: Bimanual training without mirroring (Control Group)
Number of subjects: 36
Study 33003179 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline
Number of subjects: 57
Study 33003179 — intervention group
Group type: COMPARATOR
Intervention: 20% mannitol
Number of subjects: 57
Study 34182189 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour urine protein collection
Number of subjects: 115
Study 34182189 — intervention group
Group type: COMPARATOR
Intervention: 24-hour urine protein collection
Number of subjects: 115
Study 32461554 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice-daily for 3 months
Number of subjects: 40
Study 32461554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary resistance to clarithromycin
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary resistance to levofloxacin
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary resistance to metronidazole
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary resistance to clarithromycin
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary resistance to levofloxacin
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary resistance to metronidazole
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to amoxicillin
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to tetracycline
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to rifampicin
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary resistance to clarithromycin (2014-2016 comparison)
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary levofloxacin resistance (stability)
Number of subjects: 951
Study 33090614 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole resistance (trend)
Number of subjects: 951
Study 32657194 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (n = 24, adhered n = 9)
Number of subjects: 42
Study 32657194 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 42
Study 35839545 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized diet
Number of subjects: 100
Study 35839545 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 100
Study 35839545 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 100
Study 34147151 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib in combination with topical corticosteroids
Number of subjects: 0
Study 34147151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32888031 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg)
Number of subjects: 545
Study 36266767 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer charity donation intervention
Number of subjects: 420
Study 34876098 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium brush (TiB)
Number of subjects: 75
Study 34876098 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (CHX)
Number of subjects: 75
Study 34876098 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush-acid
Number of subjects: 75
Study 34876098 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush-laser
Number of subjects: 75
Study 34876098 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 75
Study 34876098 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid (CA)
Number of subjects: 75
Study 34876098 — intervention group
Group type: COMPARATOR
Intervention: Negative control (PBS)
Number of subjects: 75
Study 34876098 — intervention group
Group type: COMPARATOR
Intervention: No-treatment group
Number of subjects: 75
Study 33525489 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week Starch- and Sucrose-Reduced Diet (SSRD), n = 80
Number of subjects: 105
Study 33525489 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet), n = 25
Number of subjects: 105
Study 33560659 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg·kg‐1 bolus followed by 5 µg·kg‐1·min‐1 infusion for up to 45 minutes)
Number of subjects: 60
Study 33560659 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study 32848185 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron supplementation (800 mg iron-carboxymaltose)
Number of subjects: 393
Study 32848185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study 35807068 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power diode laser
Number of subjects: 57
Study 35807068 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 57
Study 32636290 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 40
Study 34534565 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat resection
Number of subjects: 250
Study 34534565 — intervention group
Group type: COMPARATOR
Intervention: Standard care with no repeat resection
Number of subjects: 250
Study 32886778 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 56
Study 32886778 — intervention group
Group type: COMPARATOR
Intervention: Single-session sleep hygiene (SH)
Number of subjects: 56
Study 33337237 — intervention group
Group type: EXPERIMENTAL
Intervention: P. foliicola spore suspension (1.0 × 10^6/ml) applied to three-week-old seedlings of mung bean cultivar 'Jilv 7' (n=5)
Number of subjects: 10
Study 33337237 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (control group, n=3)
Number of subjects: 10
Study 32969088 — intervention group
Group type: EXPERIMENTAL
Intervention: Video consultations combined with regular outpatient care
Number of subjects: 240
Study 32969088 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 240
Study 34575354 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (6 months)
Number of subjects: 289
Study 35793222 — intervention group
Group type: EXPERIMENTAL
Intervention: RBOP2 design
Number of subjects: 0
Study 33161523 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 71
Study 33161523 — intervention group
Group type: COMPARATOR
Intervention: Control group (primary wound closure)
Number of subjects: 71
Study 32213737 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorb BVS
Number of subjects: 400
Study 32213737 — intervention group
Group type: COMPARATOR
Intervention: XIENCE (DES)
Number of subjects: 400
Study 35940768 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich diet
Number of subjects: 51
Study 34869187 — intervention group
Group type: EXPERIMENTAL
Intervention: SINEMA intervention
Number of subjects: 637
Study 33403333 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass fibre post (GFP) with Z350 resin composite core
Number of subjects: 60
Study 33403333 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐fabricated metal post (PMP) with Z350 resin composite core
Number of subjects: 60
Study 33403333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast metal core (CMC) with silver‐tin alloy
Number of subjects: 60
Study 36125701 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg QD
Number of subjects: 3117
Study 36125701 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg QD
Number of subjects: 3117
Study 36125701 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib (15 mg or 30 mg QD)
Number of subjects: 3117
Study 36125701 — intervention group
Group type: EXPERIMENTAL
Intervention: RAPID3 scores
Number of subjects: 3117
Study 33853797 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophobic PICC (with pressure-activated valve)
Number of subjects: 1098
Study 33853797 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-impregnated PICC (with external clamp)
Number of subjects: 1098
Study 33853797 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyurethane PICC (with external clamp)
Number of subjects: 1098
Study 33853797 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 1098
Study 33773577 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined protocol (lidocaine + Huffing maneuver)
Number of subjects: 400
Study 33773577 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 400
Study 33773577 — intervention group
Group type: EXPERIMENTAL
Intervention: Huffing maneuver
Number of subjects: 400
Study 33773577 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 400
Study 35675229 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lacticaseibacillus rhamnosus HN001
Number of subjects: 483
Study 35675229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study 35530165 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation training
Number of subjects: 0
Study 35530165 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 0
Study 33657294 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 300
Study 33657294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 36194311 — intervention group
Group type: EXPERIMENTAL
Intervention: Talk-to-Me MOOC
Number of subjects: 129
Study 36194311 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 129
Study 33779259 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculated with isolate DAL-59 (Diaporthe amygdali) using colonized agar plugs (3 mm diameter) inserted into 3 mm wounds.
Number of subjects: 12
Study 33779259 — intervention group
Group type: COMPARATOR
Intervention: Control group inoculated with uncolonized PDA plugs.
Number of subjects: 12
Study 33236939 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVr) plus guideline directed medical therapy (GDMT)
Number of subjects: 0
Study 33236939 — intervention group
Group type: COMPARATOR
Intervention: Guideline directed medical therapy (GDMT) alone
Number of subjects: 0
Study 36199248 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir plus usual care
Number of subjects: 1281
Study 36199248 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 1281
Study 34543475 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenograft blocks infused with BMP-2
Number of subjects: 24
Study 34543475 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone blocks
Number of subjects: 24
Study 35292423 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (15 mg once daily)
Number of subjects: 7213
Study 35292423 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg daily)
Number of subjects: 7213
Study 35292423 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban and Aspirin (both groups)
Number of subjects: 7213
Study 33127308 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Distance (BD) partition method
Number of subjects: 60
Study 33127308 — intervention group
Group type: EXPERIMENTAL
Intervention: D10 partition method
Number of subjects: 60
Study 33127308 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional CV partition method
Number of subjects: 60
Study 33127308 — intervention group
Group type: COMPARATOR
Intervention: Normal control
Number of subjects: 60
Study 33127308 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild cognitive impairment
Number of subjects: 60
Study 34378842 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based nursing interventions
Number of subjects: 78
Study 34378842 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing interventions (Control)
Number of subjects: 78
Study 32534142 — intervention group
Group type: EXPERIMENTAL
Intervention: Delafloxacin
Number of subjects: 520